寨卡病毒感染的体液免疫应答及既往黄病毒免疫的重要性
本文综述寨卡病毒(ZIKV)诱导的B细胞应答与体液交叉反应性研究,指出多个研究组已证实ZIKV与其他黄病毒存在免疫交叉反应,并鉴定出可交叉中和及介导抗体依赖性增强(ADE)的抗体;但既往黄病毒免疫对ZIKV致病、保护性应答及宫内传播的影响尚不清楚。鉴于登革病毒(DENV)在ZIKV疫情最严重地区的广泛流行,ADE可能性尤其令人担忧,可能给安全免疫原性ZIKV疫苗的研发与部署带来独特挑战。
要点
- 寨卡病毒(ZIKV)诱导的B细胞应答功能质量和抗原靶点已获深入解析。
- 已鉴定出可交叉中和及介导抗体依赖性增强(ADE)的抗体。
- 既往黄病毒免疫对ZIKV致病与传播的影响尚不清楚。
核心结论
- ZIKV与其他黄病毒存在免疫交叉反应,可产生交叉中和抗体及介导ADE的抗体。
- 既往黄病毒免疫对ZIKV致病、保护性应答及宫内传播的影响尚不清楚。
- DENV广泛流行地区ADE可能性尤其令人担忧,可能给安全免疫原性ZIKV疫苗研发部署带来独特挑战。
研究设计与样本
- 本文为综述,汇总ZIKV诱导B细胞应答及体液交叉反应性的当前文献。
主要发现
- 多个研究组证实ZIKV与其他黄病毒存在免疫交叉反应。
- 已鉴定出可交叉中和以及介导抗体依赖性增强(ADE)ZIKV感染的抗体。
临床怎么用
- 作者讨论了针对ZIKV疫苗和治疗药物研发的相关考虑。
局限性
- 既往黄病毒免疫对ZIKV致病、保护性应答及宫内传播的影响尚不清楚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent emergence of Zika virus (ZIKV) in the western hemisphere has been linked to Guillain-Barre syndrome, congenital microcephaly, and devastating ophthalmologic and neurologic developmental abnormalities. The vast geographic spread and adverse disease outcomes of the 2015-2016 epidemic have elevated ZIKV from a previously understudied virus to one of substantial public health interest worldwide. Recent efforts to dissect immunological responses to ZIKV have provided significant insights into the functional quality and antigenic targets of ZIKV-induced B-cell responses. Several groups have demonstrated immunological cross-reactivity between ZIKV and other flaviviruses and have identified antibodies capable of both cross-neutralization, as well as antibody-dependent enhancement (ADE) of ZIKV infection. However, the impact of preexisting flavivirus immunity on ZIKV pathogenesis, the generation of protective responses, and in utero transmission of ZIKV infection remain unclear. Given the widespread endemicity of DENV in the areas most effected by the current ZIKV outbreak, the possibility of ADE is especially concerning and may pose unique challenges to the development and deployment of safe and immunogenic ZIKV vaccines. Here, we review current literature pertaining to ZIKV-induced B-cell responses and humoral cross-reactivity and discuss relevant considerations for the development of vaccines and therapeutics against ZIKV.
引用
- Priyamvada L, Suthar MS, Ahmed R, et al. Humoral Immune Responses Against Zika Virus Infection and the Importance of Preexisting Flavivirus Immunity. J Infect Dis. 2017. PMID: 29267924. doi:10.1093/infdis/jix513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。